Insights

License-led expansion Bactiguard relies on licensing partnerships to apply its ultra-thin noble metal coating to medical devices across Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Sales opportunity: target strategic medical device manufacturers in these areas to license or co-develop infection-prevention coatings for their devices.

Hospital infection needs The company targets infection prevention where high medical need exists, offering solutions that reduce infections and antimicrobial resistance. Sales play: position coating technology as a differentiator for device lines facing strict infection control requirements and high costs from infections.

Product portfolio synergies In addition to coatings, Bactiguard has a portfolio of wound management products and historically launched specific devices like the BIP Foley TempSensor. Selling angle: identify wound care and catheter/monitoring device manufacturers seeking integrated infection-prevention and patient-monitoring solutions.

Leadership and timing Recent C-suite and leadership changes, including a new CEO appointed in 2024 and a CFO hire in 2023, indicate strategic realignment. Sales approach: engage at the strategic level with partnerships and licensing opportunities, leveraging fresh leadership to push growth initiatives.

Financial and market position Revenue is under one million with a $15 million funding base, and the company is Nasdaq Stockholm listed in the Mid-Cap segment. Opportunity: collaborate with potential co-development or minority investment discussions to scale licensing deals and accelerate market adoption in target regions.

Similar companies to Bactiguard AB

Bactiguard AB Tech Stack

Bactiguard AB uses 8 technology products and services including LinkedIn Ads, HubSpot Analytics, Microsoft Clarity, and more. Explore Bactiguard AB's tech stack below.

Media & News

Bactiguard AB's Email Address Formats

Bactiguard AB uses at least 4 email formats:
Bactiguard AB Email FormatsExamplePercentage
First.Last@bactiguard.comJohn.Doe@bactiguard.com
95%
First.MiddleLast@bactiguard.comJohn.MichaelDoe@bactiguard.com
2%
FLast@bactiguard.comJDoe@bactiguard.com
2%
F_Last@bactiguard.comJ_Doe@bactiguard.com
1%

Frequently Asked Questions

What is Bactiguard AB's official website and social media links?

Minus sign iconPlus sign icon
Bactiguard AB's official website is bactiguard.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Bactiguard AB generate?

Minus sign iconPlus sign icon
As of August 2026, Bactiguard AB's annual revenue is estimated to be <$1M.

What is Bactiguard AB's NAICS code?

Minus sign iconPlus sign icon
Bactiguard AB's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Bactiguard AB have currently?

Minus sign iconPlus sign icon
As of August 2026, Bactiguard AB has approximately 96 employees across 4 continents, including Europe, Asia and North America. Key team members include Ceo: C. L., Ceo: C. K. and Ceo: C. E. Explore Bactiguard AB's employee directory with LeadIQ.

What industry does Bactiguard AB belong to?

Minus sign iconPlus sign icon
Bactiguard AB operates in the Medical Equipment Manufacturing industry.

What technology does Bactiguard AB use?

Minus sign iconPlus sign icon
Bactiguard AB's tech stack includes LinkedIn Ads, HubSpot Analytics, Microsoft Clarity, Power BI, WordPress, Cookiebot, Microsoft 365 and DocuSign.

What is Bactiguard AB's email format?

Minus sign iconPlus sign icon
Bactiguard AB's email format typically follows the pattern of First.Last@bactiguard.com. Find more Bactiguard AB email formats with LeadIQ.

How much funding has Bactiguard AB raised to date?

Minus sign iconPlus sign icon
As of August 2026, Bactiguard AB has raised $15M in funding. The last funding round occurred on Jan 29, 2021 for $168K.

When was Bactiguard AB founded?

Minus sign iconPlus sign icon
Bactiguard AB was founded in 2005.
Bactiguard AB logo

Bactiguard AB

Medical Equipment ManufacturingStockholm, Sweden51-200 Employees

Bactiguard AB is a Stockholm-based MedTech company that develops and licenses infection-prevention technology for medical devices. Its core approach uses a thin noble metal coating designed to reduce bacterial adhesion and biofilm formation, aiming to lower infection rates in healthcare settings. The company focuses on five therapeutic areas—orthopedics, cardiology, neurology, urology, and vascular access—and also maintains a portfolio of wound management products, with partnerships that apply its technology to devices produced by other medical technology firms. Bactiguard serves a global market through licensing agreements with leading MedTech companies, positioning itself within the medical equipment manufacturing industry as a provider of infection-prevention solutions that address antimicrobial resistance and patient safety. The business is headquartered in Stockholm and is publicly listed on Nasdaq Stockholm in the Mid-Cap segment, with ongoing leadership changes noted in recent announcements.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2005
Employees
51-200

Section iconFunding & Financials

  • $15M

    Bactiguard AB has raised a total of $15M of funding over 2 rounds. Their latest funding round was raised on Jan 29, 2021 in the amount of $168K as a Grant.

  • <$1M

    Bactiguard AB's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.